I am not medically trained
How AOD 9604 Differs From the Peptides It Gets Grouped With AOD 9604 is frequently mentioned alongside compounds like CJC-1295, Ipamorelin, and other growth-hormone-related peptides, which leads to the assumption that protocols are interchangeable
This means it stimulates GLP-1 receptors to reduce appetite and enhance insulin secretion, while blocking GIP signaling, which may help prevent fat storage
These include the following: Medications Pain medication is often the go-to line of treatment for people experiencing nerve pain
* Nerve damage * Blood clots Very rare side effects (may affect up to 1 in 10,000 people): * Cardiac arrest **Important Information:** * This is not an exhaustive list
Key scientific figures and citations AOD9604 is a synthetic peptide analogue of the lipolytic domain of human growth hormone that has been shown to reduce body weight in obese rodents without the diabetogenic effects of intact hGH. Ng FM